Tecnologia sanitaria
Società Argentina impegnate nel settore: tecnologia sanitaria
Queste Società Argentina operano nello stesso settore, tecnologia sanitaria. Vengono fornite quotazioni, variazioni e altre statistiche per aiutarti a ottenere il massimo livello di dettaglio. L'elenco contiene titoli adatti a qualsiasi strategia: giganti a grande capitalizzazione come le ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), top gainer come le MERCK & CO INC CEDEAR EAC 5 RE 1 (USD) e altri ancora. Filtra l'elenco e controlla le performance delle aziende in modo pratico.
Simbolo | Cap mercato | Prezzo | Variazione % | Volume | Volume rel | P/E | EPS dil TTM | EPS diluito crescita TTM YoY | Rendimento div % TTM | Rating analisti |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 871,93 T ARS | 15,850 USD | +0,32% | 108 | 0,20 | 84,26 | 193,92 ARS | +391,73% | 0,29% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 871,93 T ARS | 18.875,000 ARS | −0,13% | 505 | 0,08 | 97,34 | 193,92 ARS | +527,09% | 0,29% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 402,69 T ARS | 10,700 USD | +1,90% | 463 | 0,60 | 31,30 | 352,44 ARS | +130,17% | 1,53% | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 402,69 T ARS | 12.950,000 ARS | +1,57% | 3,19 K | 0,06 | 36,74 | 352,44 ARS | +193,52% | 1,53% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 402,69 T ARS | 1.300,000 ARS | 0,00% | 35 | 0,96 | — | — | — | — | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 369,06 T ARS | 19,900 USD | +5,29% | 28 | 0,29 | 9,66 | 2.124,76 ARS | +107,54% | 1,63% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 369,06 T ARS | 24.275,000 ARS | +1,25% | 208 | 0,18 | 11,42 | 2.124,76 ARS | +164,67% | 1,63% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 242,77 T ARS | 33,700 USD | +3,22% | 23 | 1,29 | 18,77 | 1.850,70 ARS | +490,19% | 0,87% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 242,77 T ARS | 40.300,000 ARS | +0,50% | 372 | 0,83 | 21,78 | 1.850,70 ARS | +652,64% | 0,87% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 241,88 T ARS | 37,150 USD | −1,46% | 6 | 0,02 | 46,94 | 815,85 ARS | +207,61% | 1,28% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 241,88 T ARS | 45.400,000 ARS | +1,85% | 346 | 0,58 | 55,65 | 815,85 ARS | +292,28% | 1,28% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 229,89 T ARS | 8.300,000 ARS | +2,85% | 117 | 0,43 | 126,61 | 65,55 ARS | +275,33% | 0,00% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 229,38 T ARS | 17,950 USD | +5,90% | 58 | 0,60 | 15,16 | 1.220,67 ARS | +12.566,98% | 1,81% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 229,38 T ARS | 21.125,000 ARS | +2,92% | 6,46 K | 1,03 | 17,31 | 1.220,67 ARS | +16.053,66% | 1,81% | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 223,99 T ARS | 32.625,000 ARS | +5,84% | 10 | 0,05 | 5,55 | 5.874,32 ARS | −4,22% | 3,42% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 215,1 T ARS | 29.775,000 ARS | +2,14% | 948 | 1,17 | 43,00 | 692,40 ARS | +225,23% | 0,14% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 167,46 T ARS | 9,600 USD | 0,00% | 30 | 1,08 | 43,91 | 225,39 ARS | −31,17% | 2,08% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 167,46 T ARS | 11.975,000 ARS | +0,63% | 266 | 0,18 | 53,13 | 225,39 ARS | −12,23% | 2,08% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 156,83 T ARS | 4.710,000 ARS | +3,63% | 926 | 1,49 | 52,56 | 89,60 ARS | +164,69% | 0,22% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 155,42 T ARS | 6,530 USD | +0,77% | 1,49 K | 1,44 | 21,20 | 317,52 ARS | — | 3,46% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 155,42 T ARS | 7.890,000 ARS | +0,38% | 6,2 K | 0,38 | 24,85 | 317,52 ARS | — | 3,46% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 142,12 T ARS | 27,500 USD | +2,04% | 3 | 0,18 | 157,94 | 179,50 ARS | −59,50% | 1,40% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 142,12 T ARS | 33.200,000 ARS | +2,47% | 133 | 0,36 | 184,95 | 179,50 ARS | −48,35% | 1,40% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 118,19 T ARS | 19,200 USD | −7,91% | 5 | 0,43 | — | −1.193,64 ARS | −353,26% | 2,59% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 118,19 T ARS | 22.550,000 ARS | +1,92% | 764 | 2,13 | — | −1.193,64 ARS | −422,98% | 2,59% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 118,18 T ARS | 26.400,000 ARS | +1,15% | 450 | 0,82 | 33,79 | 781,38 ARS | +170,70% | 1,89% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 78,2 T ARS | 9,220 USD | +0,44% | 107 | 2,20 | 27,25 | 348,78 ARS | +40,76% | 2,86% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 78,2 T ARS | 11.250,000 ARS | +2,04% | 16 | 0,02 | 32,26 | 348,78 ARS | +79,50% | 2,86% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 24,8 T ARS | 6.110,000 ARS | −0,16% | 4,03 K | 0,50 | — | — | — | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 21,19 T ARS | 10,500 USD | −4,55% | 6 | 0,40 | 13,91 | 778,26 ARS | +284,16% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 21,19 T ARS | 12.975,000 ARS | −1,70% | 203 | 0,15 | 16,67 | 778,26 ARS | +389,90% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 14,63 T ARS | 1,840 USD | −2,90% | 31 | 0,06 | — | −419,57 ARS | −85,22% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 14,63 T ARS | 2.205,000 ARS | −4,96% | 20,84 K | 0,15 | — | −419,57 ARS | −136,20% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 125,97 B ARS | 1.555,000 ARS | −2,81% | 106 | 0,03 | 16,15 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5,02 B ARS | 120,000 ARS | +1,69% | 207 | 0,17 | 28,11 | 4,27 ARS | +64,50% | 0,00% | — |